Experimental basis of platelet aggregation inhibition by acetylsalicylic acid
- PMID: 6083947
Item in Clipboard
Experimental basis of platelet aggregation inhibition by acetylsalicylic acid
Folia Haematol Int Mag Klin Morphol Blutforsch.
1984.
Abstract
The difference in the effectiveness of aspirin for the prevention of stroke and secondary prevention of myocardial infarction was discussed on the basis of inhibition of platelet aggregation.
Similar articles
-
Current status of platelet inhibitor therapy in coronary artery disease.Coll Works Cardiopulm Dis. 1982 May;23:1-3. Coll Works Cardiopulm Dis. 1982. PMID: 7047065 Review. No abstract available.
-
[Secondary prevention of TIA and stroke. How much must thrombocytes not be inhibited?].MMW Fortschr Med. 2004 Jun 10;146(24):50. MMW Fortschr Med. 2004. PMID: 15366495 German. No abstract available.
-
[Thrombocyte function inhibitors in stroke prevention. Ticlopidine as an alternative to acetylsalicylic acid].Fortschr Med. 1994 Sep 30;112(27):365-6. Fortschr Med. 1994. PMID: 7988969 German. No abstract available.
-
[Platelet function inhibition and anticoagulation in coronary, cerebral and peripheral arterial occlusive disease. 2. Secondary prevention].Fortschr Med. 1982 May 13;100(18):825-30. Fortschr Med. 1982. PMID: 7095698 German.
-
[Aspirin as a platelet antiaggregant: indications and controversies].Ther Umsch. 1987 Aug;44(8):584-90. Ther Umsch. 1987. PMID: 3313789 Review. French. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical